W10294A is a bioactive compound. References: Troger A, Siepermann M, Mahotka C, Wethkamp N, Bülle H, Laws HJ, Escherich G, Janka-Schaub G, Gobel U, Dilloo D. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia. Klin Padiatr. 2007 May-Jun;219(3):127-33. PubMed PMID: 17525905.

纯度：≥98%

CAS：41806-51-3